Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir Extension in HBV-induced Liver Fibrosis and Cirrhosis
NCT02849132Phase 4Active, not recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Jan 2016
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir in hepatitis B (HBV), Liver cirrhosis (LC), sponsored by Beijing Friendship Hospital. Started Jan 2016; status: active, not recruiting.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT02849132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02849132.